Medical/Pharmaceuticals

Stem Cells for Everyone: Revolutionizing Regenerative Medicine with Mass Manufacturing of Induced Pluripotent Stem Cells (iPSCs)

PALO ALTO, Calif., July 15, 2020 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe , https://ipeace.com/ ), a Palo Alto-based biotech startup focusing on Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs) has successfully developed a novel system to mass man...

2020-07-16 00:00 168

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

SONGDO, South Korea, July 15, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics held a signing ceremony today for a contract to develop and manufacture five candidate molecules, expanding upon the two companies' existing CDO partnership first established in 2018. ...

2020-07-15 13:46 413

Bridge Biotherapeutics becomes BaseLaunch's first Asia Pacific partner

SEONGNAM, South Korea and BASEL, Switzerland, July 14, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc.(KOSDAQ: 288330), a clinical stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunch, theBasel Area -based biotech venture accelerator and incubator, today announces tha...

2020-07-15 07:00 1035

Discover the Power of VUNO's AI Solutions at ECR 2020

SEOUL, South Korea, July 14, 2020 /PRNewswire/ -- VUNO Inc., South Korean artificial intelligence (AI) developer announced that it will attend the European Congress of Radiology 2020 (ECR 2020) to be held from July 15 to July 19, 2020 to showcase the power of its flagship AI radiology solutions t...

2020-07-14 22:20 474

Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA

SHANGHAI, July 14, 2020 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) announces that its subsidiary Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. ("Fosun Pharmaceutical Industrial") has received the acceptance no...

2020-07-14 20:00 1404

Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology

Shanghai, July 13, 2020 /PRNewswire/ -- Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its$32mn Series A financing led by Morningside Ventures, together with its existing investors. Arctic V...

2020-07-14 09:30 568

NTHU Research Team Develops a Rapid Test Kit for Potential Severe Covid-19 Cases

HSINCHU, July 13, 2020 /PRNewswire/ -- Professor Cheng Chao-Min of the Institute of Biomedical Engineering at National Tsing Hua University has recently developed a new covid-19 rapid test kit which allows the physician to provide timely treatment to high-risk patients, thereby making more effici...

2020-07-14 01:00 369

Mallinckrodt and Terumo BCT Announce Positive Recommendations for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Treatment of Cutaneous T-Cell Lymphoma (CTCL) in Adults

– In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement based on a favorable clinical and cost-effectiveness comparison – STAINES-UPON-THAMES, United Kingdom and LAKEWOOD, Colorado, July 13, 2020 /PRNewswire/ -- Mallinckr...

2020-07-13 06:00 3200

Samsung Biologics signs additional development and manufacturing agreement with STCube

SONGDO, South Korea, July 11, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM418, an anti-PD1 immuno-oncology candidate. STM418 received much attention from the biopha...

2020-07-12 08:00 704

United Imaging Announces New Technology That Advances Molecular Imaging, Hints at a Series of New Announcements

HOUSTON, July 11, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, continues to set a new standard in molecular imaging and redefine nuclear medicine. The company has begun unveiling new technology that showcases more of its all-digital ...

2020-07-11 20:00 735

Carromex Unveils Pharma Leads, a Groundbreaking Cloud-based Platform for Rapid Drug Analysis and Discovery

SYDNEY and MELBOURNE, Australia, July 9, 2020 /PRNewswire/ -- Carromex, a mathematical research-based innovation company based inAustralia, unveiled a new cloud-based pharmaceutical software platform called Pharma Leads  https://carromex.com/products/pharma-leads/

2020-07-10 11:31 376

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series "Collaborations That Transform," highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary w...

2020-07-09 16:32 496

Asieris Received China NMPA's Approval to Start a Global Phase III Clinical Trial for APL-1702 to Treat Cervical Precancerous Lesions (HSIL)

SHANGHAI, July 8, 2020 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a China-based biotech company with global aspirations to discover, develop and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today it has received Clinical Trial Ap...

2020-07-08 22:00 525

ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States

DAEJEON, South Korea, July 7, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO). A patent...

2020-07-08 01:00 429

Senhwa Biosciences's Silmitasertib Receives Rare Pediatric Disease Designation from U.S. FDA for Treatment of Recurrent Sonic Hedgehog Medulloblastoma

TAIPEI and SAN DIEGO, July 7, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on Next Generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) ...

2020-07-07 21:00 785

A Breakthrough in Cancer Treatment: Soundny Presents a New Drug-based Alternative in Fight Against Cancer

WUHAN, China, July 7, 2020 /PRNewswire/ -- Hubei Soundny Biotechnology ("Soundny" or the "Company"), a leading biotechnology company dedicated to developing cancer treatments, has announced the publication of its latest findings on cholangiocarcinoma in Nature Biomedical Engineering, a Nature pu...

2020-07-07 13:25 364

General Biologicals Corporation (GBC) Develops COVID-19 Testing Solutions for Antigen and Antibody Detection

TAIPEI, July 6, 2020 /PRNewswire/ -- General Biologicals Corporation (GBC), a Taiwanese medical device company has developed the GB SARS-CoV-2 Real-Time RT-PCR ("PCR Kit"): a reliable molecular testing kit for the detection of the novel coronavirus in humans. This comes amid the continued global ...

2020-07-06 18:23 433

SonoScape Flagship 4-LED equipped FHD Endoscopy System was seen in Live Demo at Conference "Endoscopy on Air"

MILAN, Italy, July 3, 2020 /PRNewswire/ -- On June 5, 2020, "Endoscopy on Air", an on-line international GI endoscopy conference led by faculties from 23 cities worldwide has attracted more than 20,000 viewers. The event touched upon the full spectrum of diagnostic and therapeutic endoscopy throu...

2020-07-03 14:47 5379

Nuctech anti-epidemic sampling isolation cabin and mobile cabin help nucleic acid testing in hospitals of Beijing

BEIJING, July 3, 2020 /PRNewswire/ -- Recently, the temperature in Beijing has been high. Every day, nucleic acid testing medics work outdoors wearing protective clothing and sweating, which is admirable and distressing.

2020-07-03 14:28 1010

New strategic partnership to develop next-generation T cell detection reagents

SHANGHAI, China and COPENHAGEN, Denmark, July 2, 2020 /PRNewswire/ -- Today two MedTech companies, Polaris Biology ofChina and Tetramer Shop of Denmark, announce a strategic partnership to co-develop and distribute technologies that accelerate T cell science. First on the agenda is to commerciali...

2020-07-02 21:00 527
12345 ... 236